DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

Dentsply Sirona demonstrated robust growth across several key segments, particularly with orthodontics experiencing double-digit revenue growth despite challenges faced by Byte in Q4/24. Wellspect Healthcare contributed to a positive financial outlook with substantial revenue increases of 15.6% and 6.9%, underpinned by consistent growth in European markets. Overall, the company's essential dental solutions reported $372 million in revenue, reflecting a 7.8% growth, indicating a solid trajectory of financial performance and bolstering the company's long-term viability.

Dentsply Sirona has revised its sales projections downward, now expecting a constant currency sales decline of -4% to -5%, compared to an earlier forecast of -2% to -4%. The company's financial metrics indicate a projected 160 basis points decline in GAAP gross margin for Q3/25, alongside an expected decrease in adjusted EBITDA margins from >19% to >18% for FY/25, reflecting broader operational challenges. Additionally, revenue in the connected technology solutions segment saw a 3.9% reported decline, with a notable drop in cash generation contributing to a negative outlook for overall financial performance.